RIGL Operating Income Growth
Rigel Pharmaceuticals Inc · Operating Income Growth
RIGL Operating Income Growth
Year-over-year change vs the same period a year earlier
Latest reported-16.77%period ending
RIGL TTM Operating Income YoY % (2.13% → -16.77%)
Year-over-year change
High-resolution chart · PNG
RIGL operating income growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Income Growth |
|---|---|
| -16.7679% | |
| 183.5765% | |
| 418.626% | |
| 1,151.7205% | |
| 1,259.7583% | |
| 398.2012% | |
| 218.0616% | |
| 146.6336% | |
| 73.7207% | |
| 64.9355% | |
| 63.1125% | |
| 74.2204% | |
| 57.3338% | |
| 47.8165% | |
| -344.5423% | |
| -698.0515% | |
| -1,961.7534% | |
| -876.4948% | |
| 56.8702% | |
| 63.9595% | |
| 84.844% | |
| 72.226% | |
| 58.0654% | |
| 44.1652% | |
| 58.1854% | |
| 55.243% | |
| 4.942% | |
| 51.472% | |
| 35.1472% | |
| 24.755% | |
| 8.708% | |
| -46.6006% | |
| -28.1388% | |
| -28.9166% | |
| -14.1595% | |
| -3.7286% | |
| -45.9748% | |
| -33.8894% | |
| -34.7834% | |
| -8.6973% | |
| 32.9% | |
| 41.3708% | |
| 43.2947% | |
| 28.501% | |
| 14.7574% | |
| -1.1156% | |
| -1.9895% | |
| 12.5493% | |
| 11.0894% | |
| 15.3601% | |
| 9.9701% | |
| 1.5351% | |
| -8.2882% | |
| -14.5905% | |
| -15.0623% | |
| -24.3913% | |
| -685.6668% | |
| -341.3074% | |
| -344.5508% | |
| -368.1268% | |
| 75.1151% | |
| 135.3557% | |
| 131.5226% | |
| 124.7088% | |
| 64.5572% | |
| 24.6986% | |
| 18.0501% | |
| 1.6395% | |
| -26.9968% | |
| -53.5542% | |
| -71.9089% | |
| -61.4424% | |
| -52.9322% | |
| -74.932% | |
| -84.7446% | |
| -110.1714% | |
| -83.6064% | |
| -11.138% | |
| 10.1728% | |
| 31.2848% | |
| 32.544% | |
| 16.0686% | |
| 15.7297% | |
| 2.0413% | |
| -13.8224% | |
| -18.9138% | |
| -39.2877% | |
| -45.7299% | |
| -34.9168% | |
| -28.4394% | |
| -10.2955% | |
| -4.8564% | |
| -14.1059% | |
| -26.0766% | |
| -48.2953% | |
| 35.0802% | |
| 29.1365% | |
| 14.6821% | |
| 2.1329% |